Product NDC: | 0574-4005 |
Proprietary Name: | Epinastine Hydrochloride |
Non Proprietary Name: | Epinastine Hydrochloride |
Active Ingredient(s): | .5 mg/mL & nbsp; Epinastine Hydrochloride |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0574-4005 |
Labeler Name: | Paddock Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090951 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111101 |
Package NDC: | 0574-4005-05 |
Package Description: | 1 BOTTLE in 1 CARTON (0574-4005-05) > 5 mL in 1 BOTTLE |
NDC Code | 0574-4005-05 |
Proprietary Name | Epinastine Hydrochloride |
Package Description | 1 BOTTLE in 1 CARTON (0574-4005-05) > 5 mL in 1 BOTTLE |
Product NDC | 0574-4005 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Epinastine Hydrochloride |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 20111101 |
Marketing Category Name | ANDA |
Labeler Name | Paddock Laboratories, Inc. |
Substance Name | EPINASTINE HYDROCHLORIDE |
Strength Number | .5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic Agonists [MoA],Adrenergic Receptor Agonist [EPC],Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |